Navigation Links
Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
Date:9/7/2007

BARCELONA, Spain, Sept. 7 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR), world leader in advanced radiotherapy solutions for treating cancer, is demonstrating its full range of technologies and products aimed at improving the speed and precision of radiotherapy at the 2007 European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain from September 8th-13th.

Among the new product introductions on show will be the Smart Segmentation(TM) feature for Varian's Eclipse(TM) treatment planning system. Smart Segmentation is the world's first fully automatic software tool that identifies and outlines organs and other structures of interest within diagnostic images of the thorax and male pelvis. Up to now, identifying structures to be irradiated or protected during radiotherapy treatments had to be done by hand. Eclipse will also display another intelligent planning tool that automatically selects the optimal treatment beam angle for each patient. Additionally, Varian will demonstrate 4D planning software to account for organ motion during precision radiotherapy treatments.

Varian will also be discussing the new high-definition multi-leaf collimator (HD120 MLC). This high-definition collimator, with increased resolution utilizing smaller leaves, will be available with the company's Trilogy(R) Tx medical linear accelerator and addresses the unique needs of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT).

Along with the market-leading On Board Imager(R) device for clinically-practical image guided radiotherapy (IGRT), Varian will also be demonstrating its Trilogy and Clinac(R) linear accelerators, its Acuity imaging device for planning and simulating treatments and its full range of planning and delivery tools for brachytherapy.

For the first time, Varian will be exhibiting its spot-scanning proton therapy solutions. Varian acquired Accel in January this year and visitors to ESTRO will be able to see how the Germany-based technology leader in particle therapy is being integrated into Varian Medical Systems. Varian can be found at Booths 8, 9 and 52.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068, neil.madle@varian.com

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Using XL1-Red Mutator Strain to Generate Esterase Variants
2. Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing
3. Detection of Apolipoprotein Gene Variants by DGGE Using the DCode System
4. Cytosolic expression of Green Fluorescent Protein (GFP) and its derivatives in the yeast Saccharomyces cerevisiae: Detection in vivo using the Varian Cary Eclipse
5. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
6. Minimizing Photobleaching of Blue Fluorescent Protein (BFP) using the Varian Cary Eclipse Fluorescence Spectrophotometer
7. Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS
8. Detection of Alprazolam and Temazepam in a Bovine Plasma Matrix Using the Varian 500-MS Ion Trap Mass Spectrometer
9. Quantitation of Oxybutynin in Rabbit Plasma Using the Varian 1200L LC/MS/MS System
10. Femtogram Sensitivity of the Antipsychotic Drugs Raclopride and Ritanserin Using a Varian 1200L LC/MS/MS
11. Quantitation of a Dinitro Flavonoid (DNF) in Rat Plasma Using the Varian 1200L LC/MS/MS System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the ... corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, and ... reason for its increasing popularity is due to its new team building format, a way ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen ... the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff ... of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, technology, ...
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
Breaking Biology Technology:
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):